Jupiter Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Jupiter Asset Management's BMRN Position: Q3 2026 in Review
Jupiter Asset Management increased its BioMarin Pharmaceuticals (BMRN) stake by 1,982% in Q3 2026, buying an estimated $14.3M and bringing the position to 238,980 shares worth $14.3M. The position accounts for 0.07% of the portfolio, ranked #283.
Jupiter Asset Management first reported a position in BMRN in Q4 2020 and has held it in 5 quarters since. 434 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Jupiter Asset Management held 238,980 shares of BioMarin Pharmaceuticals worth $14.3M as of Q3 2026.
- Jupiter Asset Management bought 227,501 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $14.3M.
- BioMarin Pharmaceuticals made up 0.07% of Jupiter Asset Management's portfolio in Q3 2026, its #283 holding.
- Jupiter Asset Management first reported a position in BioMarin Pharmaceuticals in Q4 2020 and has held it in 5 quarters since.
- 434 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Jupiter Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.